IL5RA: Interleukin-5 receptor subunit alpha
A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.
Cell surface receptor that plays an important role in the survival, differentiation, and chemotaxis of eosinophils.
- Drugs that act on it: 1
- With a US drug page: 1
- Type: Protein
Drugs That Act on It
Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page| Drug | US approval | Mechanism | Action | Warnings |
|---|---|---|---|---|
| Benralizumab | Approved | Interleukin-5 receptor subunit alpha inhibitor | Inhibitor | — |
Diseases Most Associated With It
Open Targets association score, 0 to 1; all associations- Asthma
- 0.61
- Airway obstruction
- 0.37
- Eosinophilic granulomatosis with polyangiitis
- 0.36
- Nasal cavity polyp
- 0.35
- Skull disorder
- 0.32
- Deficiency anemia
- 0.32
- Chronic rhinosinusitis with nasal polyps
- 0.31
- Nasal polyposis
- 0.30
- Bronchiectasis
- 0.26
Drugs and mechanisms are from ChEMBL CHEMBL3580483 (CC BY-SA 3.0). Gene name, function (UniProt Q01344, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets